Target intelligence / Profile preview

CASK interacting protein 2 (CASKIN2)

Target
CASKIN2
Molecular classification
Other (Scaffold/adaptor protein), Sterile alpha motif (SAM) domain-containing protein, Ankyrin repeat domain-containing protein
01

Overview

CASK interacting protein 2 (CASKIN2) is a large, multidomain neuronal scaffold protein characterized by six ankyrin repeats, a Src homology 3 (SH3) domain, and two sterile alpha motif (SAM) domains, along with extended proline-rich and conserved C-terminal regions[1][2][3][4]. It plays a key role in organizing postsynaptic protein complexes and modulating synaptic plasticity by nucleating large macromolecular assemblies at synaptic sites[1][3]. Although highly homologous to CASKIN1, CASKIN2 lacks a direct CASK interaction domain, leading to unique signaling roles. CASKIN2 binds talin and Abi1, linking integrin-mediated adhesion to cytoskeletal reorganization and migration, particularly in the context of some tumors[2]. In the nervous system, knockout studies indicate essential functions in memory, recognition, dendritic spine morphology, and synaptic receptor phosphorylation[1]. CASKIN2 can polymerize via its SAM domains into dimeric repeat units, a property thought to allow dynamic macromolecular assembly and organization at signaling sites[3][4]. Currently, no drugs are known to modulate CASKIN2, nor is it used as a diagnostic biomarker.

Other names
ANKS5BCaskin-2KIAA1139FLJ21609CASKIN2caskin-2
02

Biological functions

Synaptic protein complex organizationModulation of synaptic plasticitySignal scaffolding at postsynaptic densityRegulation of cytoskeletal organizationPromotes cell migration (especially in some cancer cell contexts)
03

Disease associations

Neuropsychiatric/neurodevelopmental disorders (implicated in synaptic development and cognitive phenotypes in knockout mice[1])Cancer (notably gene amplification and increased motility in some breast cancer cell lines[2])Other (mechanistic role in migration and cytoskeletal signaling may underlie additional diseases, but evidence is not definitive)

Beyond the preview

Go deeper on CASK interacting protein 2 (CASKIN2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CASK interacting protein 2 (CASKIN2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call